Chapter title |
Product Development and Commercialization of Diagnostic or Life Science Products for Scientists and Researchers
|
---|---|
Chapter number | 26 |
Book title |
Molecular Profiling
|
Published in |
Methods in molecular biology, January 2017
|
DOI | 10.1007/978-1-4939-6990-6_26 |
Pubmed ID | |
Book ISBNs |
978-1-4939-6989-0, 978-1-4939-6990-6
|
Authors |
Meghan M. Alonso |
Editors |
Virginia Espina |
Abstract |
Commercializing a diagnostic or life science product often encompasses different goals than that of research and grant funding. There are several necessary steps, and a strategy needs to be well defined in order to be successful. Product development requires input from and between various groups within a company and, for academia, outside entities. The product development stakeholder groups/entities are research, marketing, development, regulatory, manufacturing, clinical, safety/efficacy, and quality. After initial research and development, much of the work in product development can be outsourced or jointly created using public-private partnerships. This chapter serves as an overview of the product development process and provides a guide to best define a product strategy. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 7 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 2 | 29% |
Student > Bachelor | 1 | 14% |
Student > Ph. D. Student | 1 | 14% |
Researcher | 1 | 14% |
Unknown | 2 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 1 | 14% |
Linguistics | 1 | 14% |
Nursing and Health Professions | 1 | 14% |
Agricultural and Biological Sciences | 1 | 14% |
Immunology and Microbiology | 1 | 14% |
Other | 0 | 0% |
Unknown | 2 | 29% |